Abstract:Background: Cirrhosis is one of the chronic liver disease in which the liver cells get fibrose and healthy tissues converted into scar tissues. The scar tissues compress the sinusoidal space in which portal vein drains, this causes pressure in portal vein and due to the backflow of blood the portal vein dilates. Portal vein dilatation in chronic liver disease patients leads to various complications. The objective of this study was to find out the frequency of portal vein dilatation in chronic liver disease patients and correlate it with age, gender, smoking, spleen size and ascites. Methods: This cross-sectional study, which involves the convenient sampling techniquewas conducted at Shangla hospital Swat conducted in 2022 with sample size of 171 patients from World Health Organization calculator, out of 171 , 2 patients did not give response, so we included 169 patients.. confidence level taken is 95%. The level of significance is 5% and Prevalence is 20%. Data was collected through a standard and validated questionnaire which included three portions. 1st portion of questionnaire contained written informed consent. 2nd portion contained demographic profile of the patient. 3rdportion of questionnaire contained all the sonographic findings. Data were analyzed through SPSS version 22. Correlation, spearman and pearson tests were applied. Result: There were total of 169 patients consisted of 102 males and 67 females. Out of 169 patients 53 were having normal portal vein diameter and 116 were having portal vein dilatation. Portal vein diameter is not affected by gender. Age and smoking are associative factors of portal vein dilatation. Ascites occurs in chronic liver disease patients due to dilated portal vein. Portal vein dilatation does not affect spleen size. Early detection of liver diseases and diagnosis of focal and diffuse parenchymal disease can be made possible with ultrasound because its first line of investigation, its efficiency is 95%, its noninvasive, easily available in the backward areas and various factors such as liver size, shape changes, liver markings, echogenicity, nodular pattern, portal vein diameter, inferior vena cava irregularity and spleen size can all be timely detected with ultrasound and life can be saved. Conclusion: It is concluded in this study that portal vein dilatation increases with age and is more common in middle aged people, gender and spleen size does not show any relation with portal vein dilatation. Ascites increases with portal vein dilatation and smoking is also an associative factor for portal vein dilatation in chronic liver disease patients. Keywords: Chronic liver disease, ultrasonography, portal vein dilatation, portal hypertension, cirrhosis, parenchymal disease.

Study of Cardiac Dysfunction in Portal Hypertension: A Single-Center Experience From Eastern India

Cardiac functions in patients with portal hypertension

Evaluation of subclinical left ventricular systolic dysfunction using two-dimensional speckle-tracking echocardiography in patients with Child-Pugh A and B cirrhosis: A case-control study

Cardiac dysfunction in patients with cirrhosis and acute decompensation

A Comparative Analysis of Heart Rate Variability Indices in Patients with Liver Cirrhosis

Frequency of Portal Vein Dilatation in Chronic Liver Diseased Patients through Ultrasound

Diagnosis and Management of Cirrhotic Cardiomyopathy

The clinical relevance of the new criteria for cirrhotic cardiomyopathy and future directions

Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased?

Systolic and diastolic dysfunction in advanced liver disease: does cirrhotic cardiomyopathy really exist?

The portal hypertension syndrome: etiology, classification, relevance, and animal models

P- 35 COMPLICATIONS ASSOCIATED TO THE LIVER TRANSPLANTATION IN PATIENTS WITH CIRRHOTIC CARDIOMYOPATHY

Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chronic Liver Failure in the COVID-19 Era

Cirrhotic cardiomyopathy: Implications for liver transplantation

The Study on Cardiac Function of Liver Cirrhosis Patients

Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality

A Focus on Diastolic Dysfunction

DIASTOLIC DYSFUNCTION IN CIRRHOTIC CARDIOMYOPATHY: A PROSPECTIVE OBSERVATIONAL COHORT STUDY ON SHORT-TERM OUTCOMES IN CIRRHOTIC PATIENTS UNDERGOING TIPS

Cardiac Health in Patients with Hepatitis B Virus-Related Cirrhosis.

Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease

Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis